IMR Press / CEOG / Volume 29 / Issue 1 / pii/2002011

Clinical and Experimental Obstetrics & Gynecology (CEOG) is published by IMR Press from Volume 47 Issue 1 (2020). Previous articles were published by another publisher on a subscription basis, and they are hosted by IMR Press on imrpress.com as a courtesy and upon agreement with S.O.G.

Original Research

Liver and kidney ultrastructural changes caused by acetylsalicylic acid treatment during pregnancy in rats

Show Less
1 Fundariio ABC School of Medicine, Brazil
2 Departmet of Pharmacology, Institute of Biomedical Sciences, Univ. of Sao Paulo (Brazil)
3 Universidade Federal de Sao Paulo School of Medicine, Brazil
4 Universidade de Mogi das Cruzes School of Medicine, Brazil
Clin. Exp. Obstet. Gynecol. 2002, 29(1), 37–39;
Published: 10 March 2002
Abstract

The worldwide use of acetylsalicylic acid (ASA) as an analgesic-antipyretic drug, including during pregnancy, prompted us to investigate its potentially deleterious effects in that condition. Pregnant rats were treated with ASA (I, IO or 100 mg/kg once a day) from the first day up to term pregnancy. No histological changes were noticed in maternal and fetal livers or kidneys when examined under light microscopy, but some definite dose-dependent effects of ASA were observed on electron microscopy examination. In livers and kidneys of pregnant rats treated with the highest doses of ASA we observed cytoplasmic derangement, mitochondrial cristolysis and abnormally shaped rough endoplasmic reticulum. Similarly, in foetal livers and kidneys from this group we observed degenerative cyto­plasmic vacuoles and ballooned mitochondria with cristae derangement and myelin figures. Our data point out the fact that both mater­nal and foetal tissues can be importantly affected by ASA at the ultrastructural level, without overt signs of toxicity.

Keywords
Rat pregnancy
Acetylsalicylic acid
Kidney
Liver
Share
Back to top